|Values are valid only on day of printing.|
Published: April 2011
Hot Topic Q&A is an opportunity for viewers to submit questions to the Hot Topic presenter. The opportunity to submit questions for this topic is now closed.
The following questions were submitted by viewers and answered by the presenters, Kevin Halling, MD, PhD and Michael Campion from the Division of Laboratory Genetics and Anatomic Pathology at Mayo Clinic in Rochester, Minnesota. Questions are presented as submitted (unedited).
How has Mayo incorporated the use of CTC in its practice?
Our Mayo Clinic oncologists have utilized this testing on select patients and have not instituted the general use of this assay for determining prognosis or monitoring of patients with metastatic breast, prostate, or colorectal cancer.